The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...

On Saturday, April 5, The Bernie Mac Foundation will hold its eighth annual Purple Carpet Fundraiser at the Orland Chateau in ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

Dr. Jad Kebbe, a pulmonologist at the University of Oklahoma Health Sciences Center, discusses the risks of inhaling wildfire smoke, including short- and long-term lung damage, and offers tips for ...

Listen to a short summary Read by Sharon R. Your browser does not support the audio element.Bridgette Ann Greer loved ...

Hiring Dalia Rayes as head of commercial for the global efzofitimod franchise slots another piece of the puzzle into place.

SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage ...

Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...

Chronic bronchitis Cystic fibrosis Emphysema Empyema Epilepsy Bronchiectasis Asthma Asbestosis Extrinsic allergic alveolitis ...

The dose-ranging study successfully enrolled 39 patients across 17 centers in 4 countries, surpassing initial enrollment targets—a testament to both the strong interest in advancing pulmonary ...

The treatment is undergoing Phase 3 trials for pulmonary sarcoidosis, a chronic autoimmune disorder, and has received multiple orphan drug designations and U.S. Fast Track status. Tyr expects topline ...